Ivan D. Horak

2006

In 2006, Ivan D. Horak earned a total compensation of $1.3M as M.D., Executive Vice President, Research and Development and Chief Scientific Officer at Enzon Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$300,000
Option Awards$357,398
Salary$461,538
Stock Awards$161,341
Other$11,296
Total$1,291,573

Horak received $461.5K in salary, accounting for 36% of the total pay in 2006.

Horak also received $300K in non-equity incentive plan, $357.4K in option awards, $161.3K in stock awards and $11.3K in other compensation.

Rankings

In 2006, Ivan D. Horak's compensation ranked 2,531st out of 7,022 executives tracked by ExecPay. In other words, Horak earned more than 64.0% of executives.

ClassificationRankingPercentile
All
2,531
out of 7,022
64th
Division
Manufacturing
776
out of 2,413
68th
Major group
Chemicals And Allied Products
154
out of 673
77th
Industry group
Drugs
89
out of 518
83rd
Industry
Biological Products, Except Diagnostic Substances
13
out of 112
88th
Source: SEC filing on April 16, 2008.

Horak's colleagues

We found four more compensation records of executives who worked with Ivan D. Horak at Enzon Pharmaceuticals in 2006.

2006

Jeffrey Buchalter

Enzon Pharmaceuticals

Chief Executive Officer

2006

Craig Tooman

Enzon Pharmaceuticals

Chief Financial Officer

2006

Ralph del Campo

Enzon Pharmaceuticals

Executive Vice President, Technical Operations

2006

Paul Davit

Enzon Pharmaceuticals

Executive Vice President, Human Resources

You may also like